Propofol 2% (20 mg/mL): Safety Considerations for Introducing a Novel Product into Hospitals
Some Canadian hospitals will need to begin using an imported double-strength (2% or 20 mg/mL) propofol 100 mL product because there is a shortage of the 1% (10 mg/mL) propofol 50 mL and 100 mL products. To mitigate the risks associated with introducing this novel product into medication-use systems, the following preliminary considerations are provided: